Dana Pizzuti, Chief Med and Development Officer at Crinetics Pharmaceuticals, Inc. (CRNX), sold 28,750 shares at $44.47 ($1.3M) on 2024-04-15, disclosed to the SEC on 2024-04-17.
Scheduled sale ($1.3M) by Chief Med and Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.47 | 14,375 | $639K | 50.0% |
| 2 | $44.47 | 14,375 | $639K | 50.0% |
| Total | $44.47 avg | 28,750 | $1.3M | 100% |
| Filing → |
| CRNX | SELL | 2025-10-03 | $209K | — | Filing → |
| CRNX | SELL | 2025-09-04 | $161K | — | Filing → |
| CRNX | SELL | 2025-08-26 | $913K | — | Filing → |